Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Release
  • Investors
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Our Culture
  • Press shift tab to select search category

    Loading...
  • Global Australia
    < Back
    • Global
    • Annual Report
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Foundation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Therapeutic Areas
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patients
  1. Home
  2. Company
  3. Leadership
  4. Christina Xinos

Christina Xinos

Back
Christina Xinos

Christina Xinos

  • Medical Director
  • Follow in LinkedIn

Christina joined Ipsen in 2023 and is an experienced medical affairs leader with skills in People Leadership, Operations and Execution. She has over 20 years pharmaceutical experience within both large pharmaceutical companies such as BMS as well as smaller biotech organisations.

IPN price

€103.50

 €1.20 (1.17%)

  • Media
  • Investors
  • Careers
  • Annual Report
  • Contact us
  • Distribution

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms and conditions
  • Cookie Policy
  • Privacy Policy

© Ipsen Pharma. All rights reserved - 2025 Date of preparation: April 2024 CRSC-AU-000016

You are now leaving the Ipsen Australia website. To continue, please click on Continue?

Continue